Covered recipient · General Payments record
TAYLOR JETTON RUYAK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2022–2023
$423.92
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.62 | 15 |
| Education | $16.24 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.72 | 8 |
| Acerta Pharma LLC | $80.79 | 2 |
| Insmed, Inc. | $43.21 | 2 |
| INOGEN, INC. | $31.85 | 1 |
| Electromed, Inc. | $18.82 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.74 | 1 |
| BAXTER HEALTHCARE | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.92 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652273 | CMS |
| ABBVIE INC. | $8.75 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652281 | CMS |
| ABBVIE INC. | $5.94 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652287 | CMS |
| ABBVIE INC. | $8.62 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652295 | CMS |
| ABBVIE INC. | $26.77 | 04/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652301 | CMS |
| ABBVIE INC. | $17.22 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652309 | CMS |
| ABBVIE INC. | $99.33 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652315 | CMS |
| ABBVIE INC. | $23.17 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009652321 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.47 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016211619 | CMS |
| AstraZeneca Pharmaceuticals LP | $63.32 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016205439 | CMS |
| Baxter Healthcare | $14.73 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000162083 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.74 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005484221 | CMS |
| Electromed, Inc. | $18.82 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 977400253 | CMS |
| Inogen, Inc. | $31.85 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040287571 | CMS |
| Insmed, Inc. | $16.24 | 02/23/2023 | Education | Undisputed | 01/23/2026 | 978790631 | CMS |
| Insmed, Inc. | $26.97 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978790677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.